Provider perspectives on challenges in treatment during psychedelic therapy.
Saved in:
| Title: | Provider perspectives on challenges in treatment during psychedelic therapy. |
|---|---|
| Authors: | Bender DA; The University of Texas at Austin Dell Medical School, Austin, TX, USA. david.bender@austin.utexas.edu.; Washington University School of Medicine, Saint Louis, MO, USA. david.bender@austin.utexas.edu., Nayak SM; The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Siegel JS; Washington University School of Medicine, Saint Louis, MO, USA.; NYU Langone Center for Psychedelic Medicine, Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA., Hellerstein DJ; Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.; New York State Psychiatric Institute, New York, NY, USA., Ercal BC; Washington University School of Medicine, Saint Louis, MO, USA., Lenze EJ; Washington University School of Medicine, Saint Louis, MO, USA. |
| Source: | Psychopharmacology [Psychopharmacology (Berl)] 2025 Oct 27. Date of Electronic Publication: 2025 Oct 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
